OHSU researchers identify promising next-generation cancer

Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.

The future of CRISPR is now

AstraZeneca selects OHSU Knight Cancer Institute as global 'partner of choice

Staci Silber Crane on LinkedIn: OHSU researchers identify promising next-generation cancer treatment

New Early Detection Test StudyNew Prospective Clinical Study of Blood-Based Early Detection Test - Let's Win Pancreatic Cancer

Promising new method treats infertility by turning skin cells into egg

Collaboration for a Cure: The Knight Cancer Research Building and the Culture of Innovation by SRG Partnership - Issuu

Danielle Wiens on LinkedIn: World Cancer Day

Stories OHSU News

Donor support sparks crucial advances in pancreatic research

LRD 2022: Program – NMIN – Nanomedicines Innovation Network

Telehealth may improve contraception care, intimate partner violence